A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

Clinical trial NCT05934838 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05934838
Sponsor: Weill Medical College of Cornell University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Follicular Lymphoma B-Cell Lymphoma Mantle Cell Lymphoma Diffuse Large B Cell Lymphoma

Start date: 2023-10-04
Primary completion: 2026-05-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.